Mohammad Jahanzeb, MD, FACP of Sylvester Comprehensive Cancer Center discusses the impact of the MONARCH-2 trial on treating patients with metastatic ER+ breast cancer. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Impact of MONARCH-2 on breast cancer treatment
